International healthcare investment group OrbiMed has raised around $4.3 billion in committed financing for distribution across three new private funds that will be used to support life sciences companies in the next few years.OrbiMed Private Investments IX is in line for $1.87 billion for private equity deals, with another $1.71 billion for OrbiMed Royalty and […]
